Nicotine replacement therapy in pregnancy: Use or avoid?

Journal of The Royal Society for the Promotion of Health

Volumn 125, Issue 5, 2005, Pages 210-211

  Coleman, Tim ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CIGARETTE SMOKE; COTININE; NICOTINE; NICOTINE GUM; PLACEBO;

ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; DRUG METABOLISM; EVIDENCE BASED MEDICINE; FEMALE; FETOTOXICITY; FETUS DEVELOPMENT; HUMAN; NICOTINE REPLACEMENT THERAPY; NONHUMAN; PRACTICE GUIDELINE; PREGNANCY; SMOKING CESSATION; SMOKING HABIT; TOBACCO DEPENDENCE; UNITED KINGDOM;

ABNORMALITIES, DRUG-INDUCED; FEMALE; FETUS; HUMANS; NICOTINE; NICOTINIC AGONISTS; PREGNANCY; PRESCRIPTIONS, DRUG; RISK ASSESSMENT; SMOKING; SMOKING CESSATION;

EID: 30344486574     PISSN: 14664240     EISSN: None     Source Type: Journal    
DOI: 10.1177/146642400512500509     Document Type: Article

References (17)

1. Owen L, Penn G. Smoking and Pregnancy: A Survey of Knowledge, Attitudes and Behaviour, 1992-1999. London: Health Development Agency, 1999
2. Smoking and the Young. A Report of a Working Party of the Royal College of Physicians. London: Royal College of Physicians, 1992
3. Charlton A. Children and smoking: the family circle. British Medical Bulletin 1996;52:90-107
4. Batstra L, Hadders-Algra M, Neeleman J. Effect of antenatal exposure to maternal smoking on behavioural problems and academic achievement in childhood: prospective evidence from a Dutch birth cohort. Early Human Development 2003;75:21-33
5. Department of Health. Smoking Kills: a White Paper on Tobacco. London: HMSO, 1998
6. Department of Health. Funding for smoking in pregnancy services 2002/03. Letter to Health Authorities (England), Chief Executives and Directors of Finance. London: Department of Health
7. Pharmacy Health Link. Improving Local Access to Smoking Cessation Therapies by Using Patient Group Directions. London: Pharmacy Health Link, 2003. Available online at: www.pharmacyhealthlink.org.uk (accessed 1 August 2005)
8. Drugs used in substance dependence. Brit Nat Formulary 2003;45:249-51
9. National Institute for Clinical Excellence. Guidance on the Use of Nicotine Replacement Therapy (NRT) and Bupropion for Smoking Cessation. Technology Appraisal Guidance No. 38. London: National Institute for Clinical Excellence, 2002
10. Fiore MC, Hatsukami DK, Baker TB. Effective tobacco dependence treatment. JAMA 2002;288(14):1768-71
11. West R, McNeill A, Raw M. Smoking cessation guidelines for health professionals: an update. Health Education Authority. Thorax 2000;55(12):987-99
12. Herbert R, Coleman T, Britton J. UK general practitioners' beliefs, attitudes and reported prescribing of nicotine replacement therapy in pregnancy. Nicotine Tobacco Res (in press)
13. Wisborg K, Henriksen TB, Jespersen LB, Secher NJ. Nicotine patches for pregnant smokers: a randomized controlled study. Obstet Gynecol 2000;96(6):967-71
14. Dempsey D, Jacob P 3rd, Benowitz NL. Accelerated metabolism of nicotine and cotinine in pregnant smokers. J Pharmacol Exp Ther 2002;301(2):594-8
15. Dempsey DA, Benowitz NL. Risks and benefits of nicotine to aid smoking cessation in pregnancy. Drug Saf 2001;24(4):277-322
16. Benowitz N, Dempsey D. Pharmacotherapy for smoking cessation during pregnancy. Nicotine Tob Res 2004;6(Suppl2):S189-202
17. Benowitz NL, Dempsey DA, Goldenberg RL, Hughes JR, Dolan-Mullen P, Ogburn PL, et al. The use of pharmacotherapies for smoking cessation during pregnancy. Tob Control 2000;9(Suppl3):III91-III94